Key takeaways
- No, and not in a small way. Ozempic is an FDA-approved product from one manufacturer. A compounded preparation is made for one patient by a pharmacy, and the FDA does not review it before it is sold.
- It is not a generic either. A generic has to prove it matches the original. Nothing in compounding requires that comparison to be made.
- The active ingredient may or may not match. The approved products use semaglutide base. The FDA says the salt forms are different active ingredients.
- Strength is the practical difference. Compounded vials come in strengths with no approved equivalent, so the same dose can be a different volume.
- Nobody has compared them head to head. Any results figure you read about semaglutide comes from trials of the approved drugs.
Everybody wants to know whether compounded semaglutide is the same as Ozempic before their first order, usually phrased as some version of “is this the real thing.” It deserves a straight answer instead of a sales pitch, so ours is below.
No. Compounded semaglutide is not the same as Ozempic, and the differences are worth understanding properly before you decide anything. Some of them are technical. One or two of them will change what you do at the kitchen table each week.
The short answer
Ozempic is a finished product. One maker builds it to one recipe, tests it, and the FDA approves it for set uses.
Compounded semaglutide is mixed by a pharmacy, to order, for one patient. No agency looked at that mix before it reached you. As the FDA puts it, compounded drugs are not FDA approved, which means the agency does not review them for safety, effectiveness or quality before they are marketed.
Those are two different categories of thing. They are not two brands of the same thing, and treating them as interchangeable is where most of the confusion in this market starts.
What FDA approved actually covers
The phrase gets thrown around loosely, so it helps to be specific about what an approval buys you.
An approved product has been through clinical trials for the uses on its label. The FDA reviewed the plant, the recipe and the testing plan. Every batch has to match the same spec. Problems go through a formal system that can trigger a recall.
A compounded vial has none of that behind it. That is not a scandal. Compounding is a long-standing and legitimate part of pharmacy, and it exists so a pharmacist can make something for a patient that no company sells in that exact form. But it is a different deal, with different protections, and you should know which one you are buying.
The trade is real in both directions. You are giving up the review, and there is no way to describe that as a technicality.
Why it is not a generic
This is the single most common misunderstanding, and it is an easy one to make.
A generic medicine is a copy that had to prove itself. The company files an application. It has to show the FDA that its version puts the same active ingredient into the blood in the same way. Only then can a pharmacist swap one for the other.
Compounding asks for no such test. Nobody has to show that a compounded vial behaves like the approved product, because that is not what compounding is for. So a compounded preparation is not a generic version of Ozempic, and there is currently no generic version of it available in the United States.
If a seller calls their product a generic, that alone tells you something useful about the seller.
The active ingredient question
The approved products use semaglutide base. Some compounders buy a salt form instead. The FDA has been direct about that:
“These salt forms, including semaglutide sodium and semaglutide acetate, are different active ingredients than are used in the approved drugs.”
The agency adds that it does not know whether those salts behave like the approved ingredient. So the answer to “is it the same active ingredient” depends on the pharmacy. If the pharmacy bought the base, yes, the active ingredient matches. If it bought a salt, the FDA’s position is that it does not.
You cannot tell from a website, because both get labeled semaglutide. You can tell by asking for the active ingredient exactly as written on the certificate of analysis. We covered how that paperwork works in what is actually in compounded semaglutide.
Six things that are genuinely different
Side by side:
| Ozempic | Compounded semaglutide | |
|---|---|---|
| Review | Approved by the FDA | Not reviewed before sale |
| Strength | Fixed, and the same every time | Set by the pharmacy, no approved equivalent |
| What you get | A pen with dose settings | A vial you draw from |
| Other ingredients | One published list | Set by the pharmacy, and it varies |
| Refill to refill | One spec every time | Can change with the recipe or the pharmacy |
| Paperwork | Medication guide and maker support | Neither |

Strength is the row that matters most. Compounded vials appear in strengths that have no approved equivalent, so the same milligram dose can be a different volume in the syringe. The FDA has received reports of adverse events, some requiring hospitalization, that may relate to dosing errors with these products. Read the milligrams per milliliter on your own label, every time.
The ingredients row is the one you can see. The Ozempic pen lists disodium phosphate dihydrate, propylene glycol, phenol and water. A compounded recipe belongs to the pharmacy, and some include vitamin B12, which turns the liquid pink.
What is the same
There are real overlaps, and they are worth stating as plainly as the differences.
Where the pharmacy used semaglutide base, the active ingredient in the vial is the same molecule that is in the approved products. Both require a prescription, and in each case a licensed clinician decides whether the medication is appropriate for you. You inject both under the skin rather than swallowing a tablet.
What we are not going to tell you is that the two produce the same outcome. We hold no data comparing them, and neither does anyone else selling this. That claim gets made constantly in this industry and it is not one we will make.
The comparison nobody can give you
Every weight figure you have read about semaglutide comes from clinical trials of the approved products. Those trials studied one maker’s medicine, at set doses, alongside diet and activity support. They also picked who took part.
No equivalent trial exists for any compounded version. There is no head-to-head study, from us or from any competitor, and the honest position is that the comparison has not been done.
So when a telehealth site quotes a percentage next to a compounded product, look at where the number came from. It is almost always borrowed from the approved-product trials, and borrowing it implies an equivalence nobody has established. We wrote about that pattern in our guide to checking any provider in this category, and it is the reason you will not find outcome percentages anywhere on this site.
Why the price is different
People ask this because of the price gap, so it is worth naming what sits behind that gap.
An approved medicine carries the cost of the trials, the approval, the factory standard and the sales machine around it. A compounded vial carries the cost of ingredients, the pharmacy’s work and the telehealth visit. Those are two different cost bases. The price gap follows from that, not from anyone being clever.
The gap is not a discount on the same item. You are buying a different arrangement with a different set of protections, and that is the trade to weigh.
Questions worth asking before you buy
- Which pharmacy fills the prescription, and what is its license number?
- Is it a 503A or a 503B pharmacy, and what does that mean for how my vial is made?
- What is the active ingredient exactly as written on the certificate of analysis?
- What strength will I receive, in milligrams per milliliter?
- Does anything else go in the vial, such as B12 or a preservative?
- Who do I call if something arrives wrong?
How a company handles those six questions tells you more than anything on its homepage does. Vagueness on any of them is an answer too.
Where we stand
Our semaglutide is compounded. It is not FDA approved, it is not a generic, and it is not Ozempic. We would rather write that on our own website than let you find it out somewhere else.
State-licensed United States 503A compounding pharmacies fill our prescriptions. We will name the pharmacy that filled yours if you ask us, and we will help you reach them for the recipe and the paperwork. Every order runs through a consult with a licensed provider licensed in your state, and the dose comes from that provider.
We publish no outcome numbers, because we have none of our own, and borrowing somebody else’s trial results would be dishonest. What we will compete on is being straight about what this is. You can see the same approach on our compounded semaglutide page and across our weight loss treatments and our peptide treatments.
If your vial has already arrived and something looks off, start with what to do when medication arrives warm.
Frequently asked questions
Is compounded semaglutide the same as Ozempic?
No. Ozempic is an FDA-approved product. One maker builds it to a recipe the FDA has reviewed. A pharmacy makes compounded semaglutide to order, against a prescription for one patient. The FDA does not review it for safety, effectiveness or quality first. They may share an active ingredient, but they are different categories of medicine with different protections around them.
Is compounded semaglutide a generic version of Ozempic?
No. The FDA approves a generic only on evidence that it delivers the same active ingredient the same way as the original. Compounded preparations go through no such comparison, because that is not what compounding is for. There is no generic Ozempic on the United States market, so any seller describing their product as one is describing it wrongly.
Does compounded semaglutide contain the same active ingredient?
Sometimes. The approved products use semaglutide base, and a pharmacy that buys the base is using the same molecule. The FDA has said that salt forms such as semaglutide sodium and semaglutide acetate are different active ingredients from those in the approved drugs. Ask for the active ingredient exactly as it appears on the certificate of analysis, because both versions get labeled semaglutide.
Does compounded semaglutide work the same as Ozempic?
Nobody can answer that from evidence, and we are not going to pretend otherwise. No head-to-head study has compared a compounded preparation with an approved product. Every published figure for semaglutide comes from trials of the approved medicines. Any seller quoting those numbers next to a compounded product is borrowing results that were not measured on what they are selling.
Why is compounded semaglutide cheaper?
Different cost base rather than a discount. An approved medicine carries the cost of trials, approval and a reviewed factory standard. A compounded vial carries the cost of ingredients, pharmacy work and the telehealth visit. You are buying a different arrangement with a different set of protections, not the same product at a lower price.
Is compounded semaglutide FDA approved?
No, and no compounded medicine is. The FDA states plainly that compounded drugs are not FDA approved and that it does not review them for safety, effectiveness or quality before they are marketed. Compounding is a legitimate and long-standing part of pharmacy, but the review that sits behind an approved product is simply not part of it.
What is the difference in dosing between the two?
An Ozempic pen has fixed dose settings built into the device. Compounded semaglutide usually arrives as a vial, and you draw the dose with a syringe. Compounded vials also come in strengths with no approved equivalent, so the same milligram dose can be a different volume. Confirm your volume with the pharmacy or your provider rather than working it out yourself.
Can my pharmacist substitute compounded semaglutide for Ozempic?
No. Swap rules cover approved generics, and a generic has to prove it matches the original. A compounded vial is made against a prescription written for it, so a pharmacist cannot swap it in for you. Any change between the two is a decision for you and the clinician who prescribes for you.
Is compounded tirzepatide the same as Mounjaro or Zepbound?
The same logic applies. Mounjaro and Zepbound are FDA-approved products from one manufacturer, and a compounded tirzepatide preparation is made by a pharmacy without that review. The FDA has also received more than 730 reports of adverse events associated with compounded tirzepatide as of 31 May 2026, alongside 990 for compounded semaglutide.
Published 8 September 2026 by Happy Care Meds. We update this article when FDA guidance changes.
This article is general information about how the rules sort these medicines. It is not medical advice, it does not tell you whether any product is right for you, and it does not describe expected results from any medication. Always follow the instructions on your pharmacy label, and contact your pharmacy or a licensed provider about your own medication.
Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Happy Care Meds is not affiliated with, endorsed by, or sponsored by either company, and the approved products named here are referred to only to describe their published labeling. Compounded medications are not FDA approved and are not generic versions of any approved drug.
Sources:
- U.S. Food and Drug Administration, “FDA’s concerns with unapproved GLP-1 drugs used for weight loss,” content current as of 1 September 2026.
- Novo Nordisk prescribing information for Ozempic (semaglutide) injection, via DailyMed.
- Eli Lilly prescribing information for Zepbound (tirzepatide) injection, via DailyMed.
- U.S. Food and Drug Administration, “Compounding and the FDA: questions and answers.”
- United States Pharmacopeia chapters 795 and 797 on compounding and beyond-use dating.